Fresenius Medical Care AG
SWB:FME
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.5B EUR |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
90.2B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
67.4B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
69.1B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25.1B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.5B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD |
Loading...
|
|
| US |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
8.5B USD |
Loading...
|
Market Distribution
| Min | -5 776.5% |
| 30th Percentile | 29.1% |
| Median | 44.6% |
| 70th Percentile | 60.9% |
| Max | 184.7% |
Other Profitability Ratios
Fresenius Medical Care AG
Glance View
Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Fresenius Medical Care AG is 25.6%, which is above its 3-year median of 25.3%.
Over the last 3 years, Fresenius Medical Care AG’s Gross Margin has increased from 25.2% to 25.6%. During this period, it reached a low of 24.5% on Mar 31, 2025 and a high of 26.6% on Mar 31, 2023.